Key facts
Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
GE HealthCare Technologies Inc. incurred term loan of $2.0 billion.
- Instrument
- term loan
- Principal
- $2.0 billion
- Event
- incurrence
Exact text from the filing
On the Distribution Date, we drew down the full $2.0 billion available under the Term Loan Agreement.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Tomislav Mihaljevic was appointed as Director at GE HealthCare Technologies Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
Tomislav Mihaljevic 58 Talent, Culture, and Compensation Committee and Nominating and Governance Committee
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Phoebe L. Yang was appointed as Director at GE HealthCare Technologies Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
Phoebe L. Yang 53 Talent, Culture, and Compensation Committee and Nominating and Governance Committee
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Peter J. Arduini was appointed as Director at GE HealthCare Technologies Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
Peter J. Arduini 58 None
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Lloyd W. Howell, Jr. was appointed as Director at GE HealthCare Technologies Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
Lloyd W. Howell, Jr. 56 Audit Committee and Talent, Culture, and Compensation Committee
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
H. Lawrence Culp, Jr. was appointed as Director at GE HealthCare Technologies Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
H. Lawrence Culp, Jr. 59 None
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Jan Makela was appointed as CEO, Imaging at GE HealthCare Technologies Inc..
- Action
- appointed
- Role
- CEO, Imaging
Exact text from the filing
Jan Makela 54 CEO, Imaging
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Risa Lavizzo-Mourey was appointed as Director at GE HealthCare Technologies Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
Risa Lavizzo-Mourey 68 Nominating and Governance Committee (Chair)
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Frank R. Jimenez was appointed as General Counsel and Corporate Secretary at GE HealthCare Technologies Inc..
- Action
- appointed
- Role
- General Counsel and Corporate Secretary
Exact text from the filing
Frank R. Jimenez 57 General Counsel and Corporate Secretary
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
William J. Stromberg was appointed as Director at GE HealthCare Technologies Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
William J. Stromberg 62 Audit Committee and Talent, Culture, and Compensation Committee (Chair)
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
George A. Newcomb was appointed as Chief Accounting Officer at GE HealthCare Technologies Inc..
- Action
- appointed
- Role
- Chief Accounting Officer
Exact text from the filing
George A. Newcomb 55 Chief Accounting Officer
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Anne T. Madden was appointed as Director at GE HealthCare Technologies Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
Anne T. Madden 58 Audit Committee and Nominating and Governance Committee
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Helmut Zodl was appointed as Chief Financial Officer at GE HealthCare Technologies Inc..
- Action
- appointed
- Role
- Chief Financial Officer
Exact text from the filing
Helmut Zodl 50 Chief Financial Officer
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Betty D. Larson was appointed as Chief People Officer at GE HealthCare Technologies Inc..
- Action
- appointed
- Role
- Chief People Officer
Exact text from the filing
Betty D. Larson 46 Chief People Officer
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Catherine Lesjak was appointed as Director at GE HealthCare Technologies Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
Catherine Lesjak 63 Audit Committee (Chair)
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Rodney F. Hochman was appointed as Director at GE HealthCare Technologies Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
Rodney F. Hochman 67 Audit Committee and Nominating and Governance Committee
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Roland Rott was appointed as CEO, U at GE HealthCare Technologies Inc..
- Action
- appointed
- Role
- CEO, U
Exact text from the filing
Roland Rott 51 CEO, U
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Peter J. Arduini was appointed as President, Chief Executive Officer, and Director at GE HealthCare Technologies Inc..
- Action
- appointed
- Role
- President, Chief Executive Officer, and Director
Exact text from the filing
Peter J. Arduini 58 President, Chief Executive Officer, and Director
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Kevin M. O’Neill was appointed as CEO, Pharmaceutical Diagnostics at GE HealthCare Technologies Inc..
- Action
- appointed
- Role
- CEO, Pharmaceutical Diagnostics
Exact text from the filing
Kevin M. O’Neill 54 CEO, Pharmaceutical Diagnostics
View on SEC.gov
M&A Transactions
SEC 8-K Item 2.01/5.01
confidence 0.95
GE HealthCare Technologies Inc. completed a disposition involving General Electric Company (closed 2023-01-03).
- Action
- disposition
- Counterparty
- General Electric Company
- Closing
- 2023-01-03
Exact text from the filing
On January 3, 2023 (the “Distribution Date”), General Electric Company (“GE”) completed the previously announced distribution of approximately 80.1% of the shares of the common stock of GE HealthCare Technologies Inc. (“GE HealthCare,” the “Company,” “we,” “us,” or “our”) by GE to holders of GE common stock on a pro rata basis (the “Spin-Off”).
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
GE HealthCare Technologies Inc. entered into Transition Services Agreement with GE (effective 2023-01-03).
- Action
- entry
- Counterparty
- GE
- Effective
- 2023-01-03
Exact text from the filing
if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 1.01 Entry into a Material Definitive Agreement. On January 3, 2023 (the “Distribution Date”), General Electric Company (“GE”) completed the previously announced distribution of approximately 80.1% of the shares of the common stock of GE HealthCare Technologies Inc.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
GE HealthCare Technologies Inc. entered into Separation and Distribution Agreement with GE (effective 2023-01-03).
- Action
- entry
- Agreement
- supply
- Counterparty
- GE
- Effective
- 2023-01-03
Exact text from the filing
if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 1.01 Entry into a Material Definitive Agreement. On January 3, 2023 (the “Distribution Date”), General Electric Company (“GE”) completed the previously announced distribution of approximately 80.1% of the shares of the common stock of GE HealthCare Technologies Inc.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
GE HealthCare Technologies Inc. entered into Trademark License Agreement with GE (effective 2023-01-03).
- Action
- entry
- Agreement
- license
- Counterparty
- GE
- Effective
- 2023-01-03
Exact text from the filing
if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 1.01 Entry into a Material Definitive Agreement. On January 3, 2023 (the “Distribution Date”), General Electric Company (“GE”) completed the previously announced distribution of approximately 80.1% of the shares of the common stock of GE HealthCare Technologies Inc.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
GE HealthCare Technologies Inc. entered into Employee Matters Agreement with GE (effective 2023-01-03).
- Action
- entry
- Counterparty
- GE
- Effective
- 2023-01-03
Exact text from the filing
if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 1.01 Entry into a Material Definitive Agreement. On January 3, 2023 (the “Distribution Date”), General Electric Company (“GE”) completed the previously announced distribution of approximately 80.1% of the shares of the common stock of GE HealthCare Technologies Inc.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
GE HealthCare Technologies Inc. entered into Tax Matters Agreement with GE (effective 2023-01-03).
- Action
- entry
- Counterparty
- GE
- Effective
- 2023-01-03
Exact text from the filing
if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 1.01 Entry into a Material Definitive Agreement. On January 3, 2023 (the “Distribution Date”), General Electric Company (“GE”) completed the previously announced distribution of approximately 80.1% of the shares of the common stock of GE HealthCare Technologies Inc.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.